Browse Category

NYSE:TMO 10 January 2026 - 22 January 2026

Thermo Fisher stock price today: TMO steadies near a 52-week high ahead of Jan. 29 earnings

Thermo Fisher stock price today: TMO steadies near a 52-week high ahead of Jan. 29 earnings

Thermo Fisher shares rose $2.03 to $638.33 Thursday afternoon, trading near a 52-week high after closing Wednesday at $636.30. Investors are watching for fourth-quarter and full-year results due Jan. 29. The company recently delisted its 3.200% senior notes due 2026 from the NYSE. Thermo Fisher earlier announced a collaboration with Nvidia on AI-based lab automation tools.
22 January 2026
Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade

Thermo Fisher stock hits fresh 52-week high as volume jumps in late trade

Thermo Fisher Scientific shares hit a 52-week high Wednesday, closing up 2.8% at $636.30 before little movement after hours. The S&P 500 and Dow also rose over 1%. The company will report earnings Jan. 29, with investors watching guidance on biopharma demand and China sales. The NYSE filed to delist Thermo Fisher’s 3.200% senior notes due 2026, affecting only the notes, not the stock.
22 January 2026
Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

Thermo Fisher (TMO) stock rises as Goldman lifts target ahead of Jan. 29 earnings

Thermo Fisher shares rose 1.6% to $628.63 by midday Wednesday, outpacing the broader market ahead of next week’s earnings release. Goldman Sachs raised its price target to $710, maintaining a “buy” rating. The NYSE notified the SEC it will delist Thermo Fisher’s 3.200% senior notes due 2026, affecting only the debt instrument. Investors await the company’s January 29 report and conference call for updates on lab demand and pharma services.
Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings

Thermo Fisher Scientific stock slips into long weekend as TMO traders eye Jan. 29 earnings

Thermo Fisher Scientific closed down 0.9% at $618.72 Friday, with little change after hours. A WARN notice filed in North Carolina showed the company will close its Asheville site, affecting 421 workers. Investors are watching for Q4 and full-year results on Jan. 29. The company recently announced a partnership with NVIDIA focused on lab automation and AI.
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher shares closed up 2.4% at $621.83 Wednesday and held steady after hours, following news of new U.S. drug manufacturing contracts. CEO Marc Casper cited a focus on reshoring production from Europe and Asia. A recent SEC filing detailed leadership changes effective in March, including COO Michel Lagarde’s exit. The company also announced a partnership with Nvidia to expand AI in lab automation.
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher Scientific’s pharma services unit secured contracts to help clients move drug manufacturing back to the U.S., CEO Marc Casper said Tuesday. Shares fell 1.4% to $607.08. The company announced new AI partnerships with Nvidia and TetraScience and confirmed COO Michel Lagarde will leave by March, with Gianluca Pettiti named as his successor. Casper cited looming tariffs and recent acquisitions as drivers for U.S. expansion.
Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up

Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up

Thermo Fisher shares fell about 0.5% after hours Monday following news of a partnership with Nvidia on AI-driven lab automation and executive departures. COO Michel Lagarde and EVP Frederick Lowery will leave in early 2026, with Marc Casper set to become chairman and CEO. Lowery will join Henry Schein as CEO in March 2026. Thermo Fisher closed regular trading at $615.45, down 0.6%.
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher shares fell 1.8% Monday after a regulatory filing showed COO Michel Lagarde and EVP Frederick M. Lowery will depart in the first quarter. The company announced new AI-focused partnerships with TetraScience and Nvidia. Investors await Tuesday’s J.P. Morgan Healthcare Conference and the Jan. 29 earnings report for further signals on demand.
Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia and Eli Lilly will invest $1 billion over five years in a joint research lab in the San Francisco Bay Area, aiming to use Nvidia’s new AI chips to accelerate drug discovery. Nvidia shares slipped 0.2% to $184.42 by 10:30 a.m. ET. Thermo Fisher Scientific will also collaborate with Nvidia on lab automation. The new site is expected to open by the end of March.
Thermo Fisher stock rises as Stifel lifts target; JPM conference and Jan. 29 earnings in focus

Thermo Fisher stock rises as Stifel lifts target; JPM conference and Jan. 29 earnings in focus

Thermo Fisher Scientific shares rose 2.04% to $618.86 Friday after Stifel raised its price target to $700 and reiterated a buy rating. CEO Marc Casper will present at the J.P. Morgan Healthcare Conference on Jan. 13. The company plans to close its Asheville, North Carolina site by the end of 2026, affecting up to 421 jobs. Investors await quarterly results due Jan. 29.
Thermo Fisher Scientific Inc stock: Weaverville phase-out plan hits tape ahead of JPM talk, Jan. 29 earnings

Thermo Fisher Scientific Inc stock: Weaverville phase-out plan hits tape ahead of JPM talk, Jan. 29 earnings

Thermo Fisher Scientific will close its Weaverville, N.C., facility by late 2027, cutting 421 jobs starting December 2026, according to a WARN notice. Shares rose 2.04% Friday to $618.86, near a record high. The company will report earnings Jan. 29 and CEO Marc Casper is scheduled to speak at the J.P. Morgan Healthcare Conference on Jan. 13.
Go toTop